---All---
  • ---All---
  • Accession
  • Catalog #

Phospho-APG4C-S451 Antibody Blocking PeptideSynthetic peptide

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
BP3364a 0.1 mg 400 ul In Stock $ 45.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

Phospho-APG4C-S451 Antibody Blocking Peptide - Product info

Primary AccessionQ96DT6
Clone Names70226149
Calculated MW52497 Da

Phospho-APG4C-S451 Antibody Blocking Peptide - Additional info

Gene ID 84938
Target/Specificity
The synthetic peptide sequence used to generate the antibody AP3364a was selected from the region of human Phospho-APG4C-S451. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Format
Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
Precautions
This product is for research use only. Not for use in diagnostic or therapeutic procedures.

Phospho-APG4C-S451 Antibody Blocking Peptide - Protein Information

Name ATG4C
Synonyms APG4C, AUTL1, AUTL3
Function
Cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes
Cellular Location
Cytoplasm (Probable).
Tissue Location
Highly expressed in skeletal muscle, heart, liver and testis

Phospho-APG4C-S451 Antibody Blocking Peptide - Related products

AP1810a: ATG4C Antibody (N-term)

AP1810b: ATG4C Antibody (Center)

AP1810c: ATG4C Antibody (C-term)

AP1810d: ATG4C Antibody

AP1810e: ATG4C Antibody

AP1810f: ATG4C Antibody

AP3364a: Phospho-ATG4C-S451 Antibody

AP3392a: Phospho-ATG4C-S177 Antibody

AP3440a: Phospho-ATG4C-S398 Antibody

AP3456a: Phospho-ATG4C-S166 Antibody

RI10456: ATG4C predesign siRNA

LY10583a: ATG4C Over-expression Lysate

BP1810a: APG4C Antibody (N-term) Blocking Peptide

BP1810b: APG4C Antibody (Center) Blocking Peptide

BP1810c: APG4C Antibody (C-term) Blocking Peptide

BP1810d: APG4C Antibody (S398) Blocking Peptide

BP1810e: APG4C Antibody (S166) Blocking Peptide

BP3364a: Phospho-APG4C-S451 Antibody Blocking Peptide

BP3392a: Phospho-APG4C-S177 Antibody Blocking Peptide

BP3440a: Phospho-APG4C-S398 Antibody Blocking Peptide

BP3456a: Phospho-APG4C-S166 Antibody Blocking Peptide

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Autophagy is the process by which endogenous proteins and damaged organelles are destroyed intracellularly. Autophagy is postulated to be essential for cell homeostasis and cell remodeling during differentiation, metamorphosis, non-apoptotic cell death, and aging. Reduced levels of autophagy have been described in some malignant tumors, and a role for autophagy in controlling the unregulated cell growth linked to cancer has been proposed. This protein is a member of the autophagin protein family. This protein is also designated as a member of the C-54 family of cysteine proteases.APG4 is a cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes.

REFERENCES

Marino G., J. Biol. Chem. 278:3671-3678(2003).Ota T., Nat. Genet. 36:40-45(2004).The MGC Project Team, Genome Res. 14:2121-2127(2004).